Aggregatibacter actinomycetemcomitans leukotoxin: From threat to therapy

Journal of Dental Research

Volumn 89, Issue 6, 2010, Pages 561-570

  Kachlany, S C ^a  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

LAP; Leukemia; Periodontitis; RTX toxin

Indexed keywords

BACTERIAL TOXIN; CYTOTOXIN; EXOTOXIN; IMMUNOSUPPRESSIVE AGENT; LEUKOTOXIN;

ACTINOBACILLUS INFECTION; ADOLESCENT; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; LEUKOCYTE; MICROBIOLOGY; PHYSIOLOGY; REVIEW;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ACTINOBACILLUS INFECTIONS; ADOLESCENT; AGGRESSIVE PERIODONTITIS; BACTERIAL TOXINS; CYTOTOXINS; EXOTOXINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES;

EID: 77953237901     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510363682     Document Type: Review

References (112)

1. Avila-Campos MJ (1995). Haemolytic activity of Actinobacillus actinomycetemcomitans strains on different blood types. Rev Inst Med Trop São Paulo 37: 215-217.
2. Baehni P., Tsai CC, McArthur WP, Hammond BF, Taichman NS (1979). Interaction of inflammatory cells and oral microorganisms. VIII. Detection of leukotoxic activity of a plaque-derived Gram-negative microorganism. Infect Immun 24: 233-243.
3. Baehni PC, Tsai CC, McArthur WP, Hammond BF, Shenker BJ, Taichman NS (1981). Leukotoxic activity in different strains of the bacterium Actinobacillus actinomycetemcomitans isolated from juvenile periodontitis in man. Arch Oral Biol 26: 671-676.
4. Baker PJ, Howe L., Garneau J., Roopenian DC (2002). T cell knockout mice have diminished alveolar bone loss after oral infection with Porphyromonas gingivalis. FEMS Immunol Med Microbiol 34: 45-50.
5. Balashova NV, Crosby JA, Al Ghofaily L., Kachlany SC (2006 a). Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans. Infect Immun 74: 2015-2021.
6. Balashova NV, Diaz R., Balashov SV, Crosby JA, Kachlany SC (2006 b). Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron. J Bacteriol 188: 8658-8661.
7. Balashova NV, Park DH, Patel JK, Figurski DH, Kachlany SC (2007). Interaction between leukotoxin and Cu,Zn superoxide dismutase in Aggregatibacter actinomycetemcomitans. Infect Immun 75: 4490-4497.
8. Balashova NV, Shah C., Patel JK, Megalla S., Kachlany SC (2009). Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells Gene 443: 42-47.
9. Balsalobre C., Silvan JM, Berglund S., Mizunoe Y., Uhlin BE, Wai SN (2006). Release of the type I secreted alpha-haemolysin via outer membrane vesicles from Escherichia coli. Mol Microbiol 59: 99-112.
10. Baumann U., Wu S., Flaherty KM, McKay DB (1993). Three-dimensional structure of the alkaline protease of Pseudomonas aeruginosa: a two-domain protein with a calcium binding parallel beta roll motif. EMBO J 12: 3357-3364.
11. Bechter OE, Eisterer W., Dirnhofer S., Pall G., Kuhr T., Stauder R., et al. (1999). Expression of LFA-1 identifies different prognostic subgroups in patients with advanced follicle center lymphoma (FCL). Leuk Res 23: 483-488.
12. Beck JD, Eke P., Heiss G., Madianos P., Couper D., Lin D., et al. (2005). Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation 112: 19-24.
13. Bergey DH, Holt JG (1994). Bergeyĝ€™s manual of determinative bacteriology. 9 th ed. Baltimore, MD, USA: Lippincot, Williams & Wilkins.
14. Berthold P., Forti D., Kieba IR, Rosenbloom J., Taichman NS, Lally ET (1992). Electron immunocytochemical localization of Actinobacillus actinomycetemcomitans leukotoxin. Oral Microbiol Immunol 7: 24-27.
15. Bhakdi S., Martin E. (1991). Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin. Infect Immun 59: 2955-2962.
16. Brogan JM, Lally ET, Poulsen K., Kilian M., Demuth DR (1994). Regulation of Actinobacillus actinomycetemcomitans leukotoxin expression: analysis of the promoter regions of leukotoxic and minimally leukotoxic strains. Infect Immun 62: 501-508.
17. Crosby JA, Kachlany SC (2007). TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans. Gene 388: 83-92.
18. Das M., Badley AD, Cockerill FR, Steckelberg JM, Wilson WR (1997). Infective endocarditis caused by HACEK microorganisms. Annu Rev Med 48: 25-33.
19. Diaz R., Ghofaily LA, Patel J., Balashova NV, Freitas AC, Labib I., et al. (2006). Characterization of leukotoxin from a clinical strain of Actinobacillus actinomycetemcomitans. Microb Pathog 40: 48-55. Dileepan T., Kachlany SC, Balashova NV, Patel J., Maheswaran SK (2007). Human CD18 is the functional receptor for Aggregatibacter actinomycetemcomitans leukotoxin. Infect Immun 75: 4851-4856. (Pubitemid 43221898)
20. Duvic M., Kuzel TM, Olsen EA, Martin AG, Foss FM, Kim YH, et al. (2002). Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK). Clin Lymphoma 2: 222-228.
21. Evans RT, Klausen B., Ramamurthy NS, Golub LM, Sfintescu C., Genco RJ (1992). Periodontopathic potential of two strains of Porphyromonas gingivalis in gnotobiotic rats. Arch Oral Biol 37: 813-819.
22. Fine DH, Kaplan JB, Kachlany SC, Schreiner HC (2006). How we got attached to Actinobacillus actinomycetemcomitans: a model for infectious diseases. Periodontol 2000 42: 114-157.
23. Fine DH, Markowitz K., Furgang D., Fairlie K., Ferrandiz J., Nasri C., et al. (2007). Aggregatibacter actinomycetemcomitans and its relationship to initiation of localized aggressive periodontitis: longitudinal cohort study of initially healthy adolescents. J Clin Microbiol 45: 3859-3869.
24. Fletcher JM, Nair SP, Ward JM, Henderson B., Wilson M. (2001). Analysis of the effect of changing environmental conditions on the expression patterns of exported surface-associated proteins of the oral pathogen Actinobacillus actinomycetemcomitans. Microb Pathog 30: 359-368.
25. Fong KP, Chung WO, Lamont RJ, Demuth DR (2001). Intra- and interspecies regulation of gene expression by Actinobacillus actinomycetemcomitans LuxS. Infect Immun 69: 7625-7634.
26. Fong KP, Pacheco CM, Otis LL, Baranwal S., Kieba IR, Harrison G., et al. (2006). Actinobacillus actinomycetemcomitans leukotoxin requires lipid microdomains for target cell cytotoxicity. Cell Microbiol 8: 1753-1767.
27. Gallant CV, Sedic M., Chicoine EA, Ruiz T., Mintz KP (2008). Membrane morphology and leukotoxin secretion are associated with a novel membrane protein of Aggregatibacter actinomycetemcomitans. J Bacteriol 190: 5972-5980.
28. Graves DT, Fine D., Teng YT, Van Dyke TE, Hajishengallis G. (2008). The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol 35: 89-105.
29. Guthmiller JM, Kolodrubetz D., Cagle MP, Kraig E. (1990 a). Sequence of the lktB gene from Actinobacillus actinomycetemcomitans. Nucleic Acids Res 18: 5291. (Pubitemid 20270090)
30. Guthmiller JM, Kraig E., Cagle MP, Kolodrubetz D. (1990 b). Sequence of the lktD gene from Actinobacillus actinomycetemcomitans. Nucleic Acids Res 18: 5292. (Pubitemid 20270091)
31. Guthmiller JM, Kolodrubetz D., Kraig E. (1995). Mutational analysis of the putative leukotoxin transport genes in Actinobacillus actinomycetemcomitans. Microb Pathog 18: 307-321.
32. Haraszthy VI, Hariharan G., Tinoco EM, Cortelli JR, Lally ET, Davis E., et al. (2000). Evidence for the role of highly leukotoxic Actinobacillus actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of early-onset periodontitis. J Periodontol 71: 912-922.
33. Haubek D., Dirienzo JM, Tinoco EM, Westergaard J., Lopez NJ, Chung CP, et al. (1997). Racial tropism of a highly toxic clone of Actinobacillus actinomycetemcomitans associated with juvenile periodontitis. J Clin Microbiol 35: 3037-3042.
34. Haubek D., Ennibi OK, Poulsen K., Poulsen S., Benzarti N., Kilian M. (2001). Early-onset periodontitis in Morocco is associated with the highly leukotoxic clone of Actinobacillus actinomycetemcomitans. J Dent Res 80: 1580-1583.
35. Haubek D., Ennibi OK, Poulsen K., Vaeth M., Poulsen S., Kilian M. (2008). Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study. Lancet 371: 237-242.
36. Hayashida H., Poulsen K., Kilian M. (2002). Differences in iron acquisition from human haemoglobin among strains of Actinobacillus actinomycetemcomitans. Microbiology 148 (Pt 12). 3993-4001. (Pubitemid 36097461)
37. He T., Nishihara T., Demuth DR, Ishikawa I. (1999). A novel insertion sequence increases the expression of leukotoxicity in Actinobacillus actinomycetemcomitans clinical isolates. J Periodontol 70: 1261-1268.
38. Hogg N., Smith A., McDowall A., Giles K., Stanley P., Laschinger M., et al. (2004). How T cells use LFA-1 to attach and migrate. Immunol Lett 92: 51-54.
39. Holland IB, Schmitt L., Young J. (2005). Type 1 protein secretion in bacteria, the ABC-transporter dependent pathway (review). Mol Membr Biol 22: 29-39.
40. Horst E., Radaszkiewicz T., Hooftman- den Otter A., Pieters R., van Dongen JJ, Meijer CJ, et al. (1991). Expression of the leucocyte integrin LFA-1 (CD11a/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade. Leukemia 5: 848-853.
41. Hritz M., Fisher E., Demuth DR (1996). Differential regulation of the leukotoxin operon in highly leukotoxic and minimally leukotoxic strains of Actinobacillus actinomycetemcomitans. Infect Immun 64: 2724-2729.
42. Inghirami G., Wieczorek R., Zhu BY, Silber R., Dalla-Favera R., Knowles DM (1988). Differential expression of LFA-1 molecules in non- Hodgkinĝ€™s lymphoma and lymphoid leukemia. Blood 72: 1431-1434.
43. Inoue T., Tanimoto I., Tada T., Ohashi T., Fukui K., Ohta H. (2001). Fermentable-sugar-level-dependent regulation of leukotoxin synthesis in a variably toxic strain of Actinobacillus actinomycetemcomitans. Microbiology 147 (Pt 10). 2749-2756. (Pubitemid 32976316)
44. Inoue T., Fukui K., Ohta H. (2006). Leukotoxin production by Actinobacillus actinomycetemcomitans. Toxin Reviews 25: 1-18.
45. Isaza MP, Duncan MS, Kaplan JB, Kachlany SC (2008). Screen for leukotoxin mutants in Aggregatibacter actinomycetemcomitans: genes of the phosphotransferase system are required for leukotoxin biosynthesis. Infect Immun 76: 3561-3568.
46. Izano EA, Wang H., Ragunath C., Ramasubbu N., Kaplan JB (2007). Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS. J Dent Res 86: 618-622.
47. Jankovic J. (2004). Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry 75: 951-957.
48. Johansson A., Claesson R., Hanstrom L., Kalfas S. (2003). Serum-mediated release of leukotoxin from the cell surface of the periodontal pathogen Actinobacillus actinomycetemcomitans. Eur J Oral Sci 111: 209-215.
49. Kachlany SC, Fine DH, Figurski DH (2000). Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans. Infect Immun 68: 6094-6100.
50. Kachlany SC, Schwartz AB, Balashova NV, Hioe CE, Tuen M., Le A., et al. (2009). Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells. Leukemia Res [Epub ahead of print] September 9, 2009 (in press).
51. Kaplan JB (2009). Therapeutic potential of biofilm-dispersing enzymes. Int J Artif Org 32: 545-554.
52. Kaplan JB, Schreiner HC, Furgang D., Fine DH (2002). Population structure and genetic diversity of Actinobacillus actinomycetemcomitans strains isolated from localized juvenile periodontitis patients. J Clin Microbiol 40: 1181-1187.
53. Kato S., Kowashi Y., Demuth DR (2002). Outer membrane-like vesicles secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin. Microb Pathog 32: 1-13.
54. Kelk P., Johansson A., Claesson R., Hanstrom L., Kalfas S. (2003). Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 71: 4448-4455.
55. Kesty NC, Mason KM, Reedy M., Miller SE, Kuehn MJ (2004). Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J 23: 4538-4549.
56. Kieba IR, Fong KP, Tang HY, Hoffman KE, Speicher DW, Klickstein LB, et al. (2007). Aggregatibacter actinomycetemcomitans leukotoxin requires beta-sheets 1 and 2 of the human CD11a beta-propeller for cytotoxicity. Cell Microbiol 9: 2689-2699.
57. Kinashi T. (2005). Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol 5: 546-559.
58. Kolodrubetz D., Dailey T., Ebersole J., Kraig E. (1989). Cloning and expression of the leukotoxin gene from Actinobacillus actinomycetemcomitans. Infect Immun 57: 1465-1469.
59. Kolodrubetz D., Phillips L., Jacobs C., Burgum A., Kraig E. (2003). Anaerobic regulation of Actinobacillus actinomycetemcomitans leukotoxin transcription is ArcA/FnrA-independent and requires a novel promoter element. Res Microbiol 154: 645-653.
60. Korostoff J., Wang JF, Kieba I., Miller M., Shenker BJ, Lally ET (1998). Actinobacillus actinomycetemcomitans leukotoxin induces apoptosis in HL-60 cells. Infect Immun 66: 4474-4483.
61. Korostoff J., Yamaguchi N., Miller M., Kieba I., Lally ET (2000). Perturbation of mitochondrial structure and function plays a central role in Actinobacillus actinomycetemcomitans leukotoxin-induced apoptosis. Microb Pathog 29: 267-278.
62. Kraig E., Dailey T., Kolodrubetz D. (1990). Nucleotide sequence of the leukotoxin gene from Actinobacillus actinomycetemcomitans: homology to the alpha-hemolysin/leukotoxin gene family. Infect Immun 58: 920-929.
63. Kuhnert P, Christensen H, editors (2008). Pasteurellaceae: biology, genomics and molecular aspects. Norfolk, UK: Caister Academic Press.
64. Lalla E., Lamster IB, Hofmann MA, Bucciarelli L., Jerud AP, Tucker S., et al. (2003). Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 23: 1405-1411.
65. Lally ET, Golub EE, Kieba IR, Taichman NS, Rosenbloom J., Rosenbloom JC, et al. (1989 a). Analysis of the Actinobacillus actinomycetemcomitans leukotoxin gene. Delineation of unique features and comparison to homologous toxins. J Biol Chem 264: 15451-15456.
66. Lally ET, Kieba IR, Demuth DR, Rosenbloom J., Golub EE, Taichman NS, et al. (1989 b). Identification and expression of the Actinobacillus actinomycetemcomitans leukotoxin gene. Biochem Biophys Res Commun 159: 256-262.
67. Lally ET, Golub EE, Kieba IR, Taichman NS, Decker S., Berthold P., et al. (1991). Structure and function of the B and D genes of the Actinobacillus actinomycetemcomitans leukotoxin complex. Microb Pathog 11: 111-121.
68. Lally ET, Golub EE, Kieba IR (1994). Identification and immunological characterization of the domain of Actinobacillus actinomycetemcomitans leukotoxin that determines its specificity for human target cells. J Biol Chem 269: 31289-31295.
69. Lally ET, Kieba IR, Sato A., Green CL, Rosenbloom J., Korostoff J., et al. (1997). RTX toxins recognize a beta2 integrin on the surface of human target cells. J Biol Chem 272: 30463-30469.
70. Lally ET, Hill RB, Kieba IR, Korostoff J. (1999). The interaction between RTX toxins and target cells. Trends Microbiol 7: 356-361.
71. Lamell CW, Griffen AL, McClellan DL, Leys EJ (2000). Acquisition and colonization stability of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in children. J Clin Microbiol 38: 1196-1199.
72. Lee SF, Andrian E., Rowland E., Marquez IC (2009). Immune response and alveolar bone resorption in a mouse model of Treponema denticola infection Infect Immun 77: 694-698.
73. Leys EJ, Griffen AL, Strong SJ, Fuerst PA (1994). Detection and strain identification of Actinobacillus actinomycetemcomitans by nested PCR. J Clin Microbiol 32: 1288-1294.
74. Löe H., Brown LJ (1991). Early onset periodontitis in the United States of America. J Periodontol 62: 608-616.
75. Macheleidt A., Muller HP, Eger T., Putzker M., Fuhrmann A., Zoller L. (1999). Absence of an especially toxic clone among isolates of Actinobacillus actinomycetemcomitans recovered from army recruits. Clin Oral Investig 3: 161-167.
76. Mangan DF, Taichman NS, Lally ET, Wahl SM (1991). Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun 59: 3267-3272.
77. Mitchell C., Gao L., Demuth DR (2003). Positive and negative cis-acting regulatory sequences control expression of leukotoxin in Actinobacillus actinomycetemcomitans 652. Infect Immun 71: 5640-5649.
78. Morova J., Osicka R., Masin J., Sebo P. (2008). RTX cytotoxins recognize beta2 integrin receptors through N-linked oligosaccharides. Proc Natl Acad Sci USA 105: 5355-5360.
79. Nagata H., Ikawa Y., Kuboniwa M., Maeda K., Shizukuishi S. (2002). Characterization of hemoglobin binding to Actinobacillus actinomycetemcomitans. Anaerobe 8: 109-114. (Pubitemid 36009088)
80. Newman MG, Socransky SS, Savitt ED, Propas DA, Crawford A. (1976). Studies of the microbiology of periodontosis. J Periodontol 47: 373-379.
81. Niederman R., Kelderman H., Socransky S., Ostroff G., Genco C., Kent R. Jr, et al. (2002). Enhanced neutrophil emigration and Porphyromonas gingivalis reduction following PGG-glucan treatment of mice. Arch Oral Biol 47: 613-618.
82. Nishino K., Yamada J., Hirakawa H., Hirata T., Yamaguchi A. (2003). Roles of TolC-dependent multidrug transporters of Escherichia coli in resistance to beta-lactams. Antimicrob Agents Chemother 47: 3030-3033.
83. Nishino K., Latifi T., Groisman EA (2006). Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium. Mol Microbiol 59: 126-141.
84. Ohta H., Kato K., Kokeguchi S., Hara H., Fukui K., Murayama Y. (1991). Nuclease-sensitive binding of an Actinobacillus actinomycetemcomitans leukotoxin to the bacterial cell surface. Infect Immun 59: 4599-4605.
85. Ohta H., Miyagi A., Kato K., Fukui K. (1996). The relationships between leukotoxin production, growth rate and the bicarbonate concentration in a toxin-production-variable strain of Actinobacillus actinomycetemcomitans. Microbiology 142 (Pt 4). 963-970.
86. Olsen E., Duvic M., Frankel A., Kim Y., Martin A., Vonderheid E., et al. (2001). Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol 19: 376-388.
87. Pacello F., Langford PR, Kroll JS, Indiani C., Smulevich G., Desideri A., et al. (2001). A novel heme protein, the Cu,Zn-superoxide dismutase from Haemophilus ducreyi. J Biol Chem 276: 30326-30334.
88. Permpanich P., Kowolik MJ, Galli DM (2006). Resistance of fluorescent-labelled Actinobacillus actinomycetemcomitans strains to phagocytosis and killing by human neutrophils. Cell Microbiol 8: 72-84.
89. Polak D., Wilensky A., Shapira L., Halabi A., Goldstein D., Weiss EI, et al. (2009). Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response. J Clin Periodontol 36: 406-410.
90. Rhodes ER, Tomaras AP, McGillivary G., Connerly PL, Actis LA (2005). Genetic and functional analyses of the Actinobacillus actinomycetemcomitans AfeABCD siderophore-independent iron acquisition system. Infect Immun 73: 3758-3763.
91. Sanchez-Magraner L., Viguera AR, Garcia-Pacios M., Garcillan MP, Arrondo JL, de la Cruz F., et al. (2007). The calcium-binding C-terminal domain of Escherichia coli alpha-hemolysin is a major determinant in the surface-active properties of the protein. J Biol Chem 282: 11827-11835.
92. Schaeffer LM, Schmidt ML, Demuth DR (2008). Induction of Aggregatibacter actinomycetemcomitans leukotoxin expression by IS1301 and orfA. Microbiology 154 (Pt 2). 528-538.
93. Schlor S., Schmidt A., Maier E., Benz R., Goebel W., Gentschev I. (1997). In vivo and in vitro studies on interactions between the components of the hemolysin (HlyA) secretion machinery of Escherichia coli. Mol Gen Genet 256: 306-319.
94. Schreiner HC, Sinatra K., Kaplan JB, Furgang D., Kachlany SC, Planet PJ, et al. (2003). Tight-adherence genes of Actinobacillus actinomycetemcomitans are required for virulence in a rat model. Proc Natl Acad Sci USA 100: 7295-7300.
95. Shenker BJ, McKay T., Datar S., Miller M., Chowhan R., Demuth D. (1999). Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J Immunol 162: 4773-4780.
96. Shenker BJ, Besack D., McKay T., Pankoski L., Zekavat A., Demuth DR (2005). Induction of cell cycle arrest in lymphocytes by Actinobacillus actinomycetemcomitans cytolethal distending toxin requires three subunits for maximum activity. J Immunol 174: 2228-2234.
97. Simpson DL, Berthold P., Taichman NS (1988). Killing of human myelomonocytic leukemia and lymphocytic cell lines by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 56: 1162-1166.
98. Slots J. (2003). Update on general health risk of periodontal disease. Int Dent J 53 (Suppl 3). 200-207.
99. Slots J., Ting M. (1999). Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol 2000 20: 82-121.
100. Spitznagel J. Jr, Kraig E., Kolodrubetz D. (1991). Regulation of leukotoxin in leukotoxic and nonleukotoxic strains of Actinobacillus actinomycetemcomitans. Infect Immun 59: 1394-1401.
101. Stanley P., Packman LC, Koronakis V., Hughes C. (1994). Fatty acylation of two internal lysine residues required for the toxic activity of Escherichia coli hemolysin. Science 266: 1992-1996.
102. Stanley P., Koronakis V., Hughes C. (1998). Acylation of Escherichia coli hemolysin: a unique protein lipidation mechanism underlying toxin function. Microbiol Mol Biol Rev 62: 309-333.
103. Taichman NS, Dean RT, Sanderson CJ (1980). Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans. Infect Immun 28: 258-268.
104. Taichman NS, Simpson DL, Sakurada S., Cranfield M., DiRienzo J., Slots J. (1987). Comparative studies on the biology of Actinobacillus actinomycetemcomitans leukotoxin in primates. Oral Microbiol Immunol 2: 97-104.
105. Tamura N., Murakami S., Oyama Y., Ishiguro M., Yamaguchi A. (2005). Direct interaction of multidrug efflux transporter AcrB and outer membrane channel TolC detected via site-directed disulfide cross-linking. Biochemistry 44: 11115-11121.
106. Tsai CC, McArthur WP, Baehni PC, Hammond BF, Taichman NS (1979). Extraction and partial characterization of a leukotoxin from a plaque-derived Gram-negative microorganism. Infect Immun 25: 427-439.
107. Tsai CC, Shenker BJ, DiRienzo JM, Malamud D., Taichman NS (1984). Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B. Infect Immun 43: 700-705.
108. van Winkelhoff AJ, Slots J. (1999). Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections. Periodontol 2000 20: 122-135.
109. Wandersman C., Delepelaire P. (1990). TolC, an Escherichia coli outer membrane protein required for hemolysin secretion. Proc Natl Acad Sci USA 87: 4776-4780.
110. Winston JL, Chen CK, Neiders ME, Dyer DW (1993). Membrane protein expression by Actinobacillus actinomycetemcomitans in response to iron availability. J Dent Res 72: 1366-1373.
111. Yamaguchi N., Kieba IR, Korostoff J., Howard PS, Shenker BJ, Lally ET (2001). Maintenance of oxidative phosphorylation protects cells from Actinobacillus actinomycetemcomitans leukotoxin-induced apoptosis. Cell Microbiol 3: 811-823.
112. Zambon JJ (1985). Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 12: 1-20.